Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene

The human iPSC lines LEIi010-A and LEIi010-B were generated from the dermal fibroblasts of a patient with Usher syndrome using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, mir302/367 microRNA and shRNA for p53. These iPSC lines carry compound heterozygous mutations (c.949C > A and...

Full description

Bibliographic Details
Main Authors: Samuel McLenachan, Elaine Y.M. Wong, Xiao Zhang, Fiona Leith, Sang Yoon Moon, Dan Zhang, Shang-Chih Chen, Jennifer A. Thompson, Terri McLaren, Tina Lamey, John N. De Roach, Marcus D. Atlas, Rodney J. Dilley, Fred K. Chen
Format: Article
Language:English
Published: Elsevier 2019-04-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506119300509
_version_ 1818264106868670464
author Samuel McLenachan
Elaine Y.M. Wong
Xiao Zhang
Fiona Leith
Sang Yoon Moon
Dan Zhang
Shang-Chih Chen
Jennifer A. Thompson
Terri McLaren
Tina Lamey
John N. De Roach
Marcus D. Atlas
Rodney J. Dilley
Fred K. Chen
author_facet Samuel McLenachan
Elaine Y.M. Wong
Xiao Zhang
Fiona Leith
Sang Yoon Moon
Dan Zhang
Shang-Chih Chen
Jennifer A. Thompson
Terri McLaren
Tina Lamey
John N. De Roach
Marcus D. Atlas
Rodney J. Dilley
Fred K. Chen
author_sort Samuel McLenachan
collection DOAJ
description The human iPSC lines LEIi010-A and LEIi010-B were generated from the dermal fibroblasts of a patient with Usher syndrome using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, mir302/367 microRNA and shRNA for p53. These iPSC lines carry compound heterozygous mutations (c.949C > A and c.1256G > T) in USH2A. LEIi010-A and LEIi010-B expressed pluripotent stem cell markers, had a normal karyotype and could be differentiated into endoderm, mesoderm and ectodermal lineages.
first_indexed 2024-12-12T19:29:39Z
format Article
id doaj.art-e3a7a0cbbc7c4e79aaca9a594d7dad71
institution Directory Open Access Journal
issn 1873-5061
language English
last_indexed 2024-12-12T19:29:39Z
publishDate 2019-04-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-e3a7a0cbbc7c4e79aaca9a594d7dad712022-12-22T00:14:26ZengElsevierStem Cell Research1873-50612019-04-0136Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A geneSamuel McLenachan0Elaine Y.M. Wong1Xiao Zhang2Fiona Leith3Sang Yoon Moon4Dan Zhang5Shang-Chih Chen6Jennifer A. Thompson7Terri McLaren8Tina Lamey9John N. De Roach10Marcus D. Atlas11Rodney J. Dilley12Fred K. Chen13Centre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, Australia; Lions Eye Institute Australia, Nedlands, Western Australia, AustraliaEar Science Institute Australia, Nedlands, Western Australia, Australia; School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia; Centre for Neurological & Neuromuscular Diseases, The University of Western Australia, Crawley, Western Australia, AustraliaCentre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, Australia; Lions Eye Institute Australia, Nedlands, Western Australia, AustraliaEar Science Institute Australia, Nedlands, Western Australia, AustraliaCentre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, AustraliaLions Eye Institute Australia, Nedlands, Western Australia, AustraliaLions Eye Institute Australia, Nedlands, Western Australia, AustraliaAustralian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Perth, Western Australia, AustraliaCentre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, Australia; Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Perth, Western Australia, AustraliaCentre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, Australia; Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Perth, Western Australia, AustraliaCentre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, Australia; Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Perth, Western Australia, AustraliaEar Science Institute Australia, Nedlands, Western Australia, Australia; Ear Sciences Centre, The University of Western Australia, Nedlands, Western Australia, AustraliaEar Science Institute Australia, Nedlands, Western Australia, Australia; Centre for Cell Therapy and Regenerative Medicine, The University of Western Australia, Australia; Ear Sciences Centre, The University of Western Australia, Nedlands, Western Australia, AustraliaCentre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, Australia; Lions Eye Institute Australia, Nedlands, Western Australia, Australia; Department of Ophthalmology, Royal Perth Hospital, Perth, Western Australia, Australia; Corresponding author at: Centre for Ophthalmology and Visual Sciences, The University of Western Australia, Nedlands, Western Australia, Australia.The human iPSC lines LEIi010-A and LEIi010-B were generated from the dermal fibroblasts of a patient with Usher syndrome using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, mir302/367 microRNA and shRNA for p53. These iPSC lines carry compound heterozygous mutations (c.949C > A and c.1256G > T) in USH2A. LEIi010-A and LEIi010-B expressed pluripotent stem cell markers, had a normal karyotype and could be differentiated into endoderm, mesoderm and ectodermal lineages.http://www.sciencedirect.com/science/article/pii/S1873506119300509
spellingShingle Samuel McLenachan
Elaine Y.M. Wong
Xiao Zhang
Fiona Leith
Sang Yoon Moon
Dan Zhang
Shang-Chih Chen
Jennifer A. Thompson
Terri McLaren
Tina Lamey
John N. De Roach
Marcus D. Atlas
Rodney J. Dilley
Fred K. Chen
Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene
Stem Cell Research
title Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene
title_full Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene
title_fullStr Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene
title_full_unstemmed Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene
title_short Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene
title_sort generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the ush2a gene
url http://www.sciencedirect.com/science/article/pii/S1873506119300509
work_keys_str_mv AT samuelmclenachan generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT elaineymwong generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT xiaozhang generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT fionaleith generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT sangyoonmoon generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT danzhang generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT shangchihchen generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT jenniferathompson generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT terrimclaren generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT tinalamey generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT johnnderoach generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT marcusdatlas generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT rodneyjdilley generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene
AT fredkchen generationoftwoinducedpluripotentstemcelllinesfromapatientwithcompoundheterozygousmutationsintheush2agene